Zevra Therapeutics Inc (ZVRA)
8.81
0.00 (0.00%)
USD |
NASDAQ |
Nov 07, 16:00
8.82
+0.01
(+0.11%)
After-Hours: 20:00
Zevra Therapeutics Revenue (TTM): 23.99M for June 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 23.99M |
| March 31, 2024 | 28.01M |
| December 31, 2023 | 27.76M |
| September 30, 2023 | 16.56M |
| June 30, 2023 | 16.54M |
| March 31, 2023 | 9.372M |
| December 31, 2022 | 10.16M |
| September 30, 2022 | 10.72M |
| June 30, 2022 | 9.812M |
| Date | Value |
|---|---|
| March 31, 2022 | 20.50M |
| December 31, 2021 | 28.65M |
| September 30, 2021 | 28.43M |
| June 30, 2021 | 28.39M |
| March 31, 2021 | 23.32M |
| December 31, 2020 | 13.29M |
| September 30, 2020 | 12.30M |
| June 30, 2020 | 21.84M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
9.372M
Minimum
Mar 2023
28.65M
Maximum
Dec 2021
19.39M
Average
20.50M
Median
Mar 2022
Revenue (TTM) Benchmarks
| Vanda Pharmaceuticals Inc | 182.02M |
| BioCardia Inc | 0.428M |
| Xeris Biopharma Holdings Inc | 181.41M |
| Crinetics Pharmaceuticals Inc | -- |
| Instil Bio Inc | -- |